查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1623511

按测试类型、产品和服务、最终用户、地区、范围和预测划分的全球呼吸诊断市场规模

Global Respiratory Diagnostics Market Size By Test Type, By Products And Services, By End User, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

呼吸诊断市场规模及预测

2020年呼吸诊断市场规模为46.9亿美元，预估2021年至2028年复合年增长率为6.3%，2028年达79.9亿美元。

肺部相关疾病和感染发病率增加、老年人口增加以及技术发展等因素正在促使市场成长。另一方面，与报销和医疗费用上升相关的风险可能会阻碍整体市场的成长。全球呼吸诊断市场报告提供了对市场的整体评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面分析。

呼吸诊断的全球市场定义

呼吸诊断是医疗领域和诊断中心最常使用的技术之一。市场成长的主要原因是年轻人生活方式的改变以及老年族群中与年龄相关的症状和疾病。

全球呼吸诊断市场概况

肺部相关疾病和感染发病率增加、老年人口增加以及技术发展等因素正在促使市场成长。另一方面，医疗费用和医疗费用上涨相关的风险可能会阻碍整体市场的成长。吸烟、饮酒、久坐的生活方式和日常生活压力的增加导致慢性阻塞性肺病和肺癌等严重呼吸道疾病的发生率增加。此外，呼吸诊断测试的多项技术创新，包括在慢性阻塞性肺病诊断和门诊管理中使用人工智慧 (AI) 和物联网 (IoT)，对市场成长产生了积极影响。

也存在一些阻碍市场成长的限制和课题。预计与 COPD 诊断和检测相关的高价格、大量未诊断和未治疗人群、严格的监管要求、缺乏认识以及报销担忧等因素限制了全球呼吸诊断市场的成长。

目录

第1章全球呼吸诊断市场：简介

  • 市场概况
  • 调查范围
  • 先决条件

第 2 章执行摘要

第3章 验证市场研究研究方法

  • 数据挖掘
  • 验证
  • 一次资料
  • 数据源列表

第4章 全球呼吸诊断市场展望

  • 概述
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 波特的五力模型
  • 价值链分析
  • 监管框架

第5章全球呼吸诊断市场：依测试类型

  • 概述
  • 机械检查
  • OSA 诊断测试
  • 影像学检查
  • 分子诊断测试
  • 其他

第6章 全球呼吸诊断市场：依产品与服务分类

  • 概述
  • 设备/装置
  • 测定和试剂
  • 服务和软体

第7章全球呼吸诊断市场：依最终用户分类

  • 概述
  • 医院/临床实验室
  • 参考实验室
  • 医生办公室
  • 其他最终用户

第8章 全球呼吸诊断市场：按地区划分

  • 概述
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 世界其他地区
    • 拉丁美洲
    • 中东/非洲

第9章 全球呼吸诊断市场：竞争格局

  • 概述
  • 企业市场排名
  • 供应商情况
  • 主要发展策略

第10章 公司简介

  • Philips Healthcare
  • Becton, Dickinson & Company
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • Cosmed
  • Seegene Inc.
  • SDI诊断

第11章附录

  • 相关研究
简介目录
Product Code: 23977

Respiratory Diagnostics Market Size And Forecast

Respiratory Diagnostics Market size was valued at USD 4.69 Billion in 2020 and is projected to reachUSD 7.99 Billion by 2028, growing at aCAGR of 6.3% from 2021 to 2028.

Factors such as increasing lung-related diseases and infections, the rise in the geriatric population, and technological developments are leading to growth in the market. On the other hand, risks associated with reimbursements and the rising healthcare cost might hinder the overall market growth. The Global Respiratory Diagnostics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Respiratory Diagnostics Market Definition

Respiratory Diagnostics is one of the most used technologies in the medicinal sector and diagnostic centers. The reason for the market growth is mainly the lifestyle changes in the young population and age-related symptoms and diseases in the geriatric population.

Global Respiratory Diagnostics Market Overview

Factors such as increasing lung-related diseases and infections, the rise in the geriatric population and technological developments are leading to the growth in the market. On the other hand, risks associated with reimbursements and the rising healthcare cost might hinder the overall market growth. The growing number of smokers and consumption of alcohol, along with sedentary lifestyle habits and stressful routines, have resulted in increased incidences of COPD and other severe respiratory conditions, such as lung cancer. Moreover, several technological innovations in respiratory diagnostic testing, counting the use of Artificial Intelligence (AI) and the Internet of Things (IoT) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth.

There are certain restraints and challenges faced which will hinder the market growth. Factors such as High price associated with COPD diagnosis and testing, a presence of a large population going undiagnosed and undertreated, Strict regulatory requirements, lack of awareness, and Reimbursement concerns are expected to restrain the growth of the global Respiratory Diagnostics Market.

Global Respiratory Diagnostics Market: Segmentation Analysis

Global Respiratory Diagnostics Market is segmented based on Test Type, Products and Services, End User, And Geography.

Respiratory Diagnostics Market, By Test Type

  • Mechanical Tests
  • OSA Diagnostic Tests
  • Imaging Tests
  • Molecular Diagnostic Tests
  • Others

Based on Test Type, the market is bifurcated into Mechanical Tests, OSA Diagnostic Tests, Imaging Tests, Molecular Diagnostic Tests, and Others. The OSA Diagnostic Tests segment is projected to account for the largest share of the market. The factors can be attributed to the quick turnaround time of these tests.

Respiratory Diagnostics Market, By Products And Services

  • Instruments and Devices
  • Assays and Reagents
  • Services and Software

Based on Products and Services, the market is bifurcated into Instruments and Devices, Assays and Reagents and Services & Software. The instruments and devices segment is anticipated to account for the largest share in the market. The factors can be attributed to the continuous requirement of diagnostic instruments and devices in point-of-care, laboratories, and home care.

Respiratory Diagnostics Market, By End User

  • Hospital/Clinical Laboratories
  • Reference Laboratories
  • Physician Offices
  • Other End Users

Based on End User, the market is bifurcated into Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices and Other End Users. The Hospital/Clinical Laboratories segment is expected to account for the largest share of the global market due to most respiratory disease diagnostics are done in hospitals as they are complex and need technologically advanced products this factor is driving the market for Hospital/Clinical Laboratories.

Respiratory Diagnostics Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, the Global Respiratory Diagnostics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share in the market will be dominated by North America. The factors can be attributed to the growing prevalence of respiratory diseases and the increasing geriatric population in the region. Furthermore, the occurrence of an advanced healthcare system and robust distribution channels for respiratory diagnostic products are other factors supporting the growth of this market in North America.

Key Players

  • The "Global Respiratory Diagnostics Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as
  • Philips Healthcare, Becton, Dickinson & Company, Abbott Laboratories, Thermo Fisher Scientific Inc., Alere Inc., Bio-Rad Laboratories, Inc., Cosmed, Seegene Inc. and Sdi Diagnostic.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Product Launches and Product Expansions
  • In June 2020, GE Healthcare launched the Thoracic Care Suite that has eight artificial intelligence (AI) algorithms that allow chest X-rays to detect abnormalities, including pneumonia detection, a symptom related to COVID-19. This new product launched by the company during the expansion of COVID-19 has enhanced the credibility of the company in the market.
  • On July 2020 BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, has announced the launch of three new diagnostic kits to significantly advance the diagnosis of COVID-19 and other respiratory illnesses.
  • May 2020, Australian medical technology company, 4DMedical has received clearance from the US Food & Drug Administration to market its XV Technology, a patented four-dimensional lung imaging process that rapidly and automatically analyses any functional lung impairment from a single X-ray. 4DMedical's US operations are based in Woodland Hills, California.
  • Acquisition and Mergers
  • May 2020, SIME, a Clinical AI company specialising in rapid ICU diagnostics, announced it has entered into an exclusive agreement with an existing strategic investor to commercialise the company's point-of-care products and services in Latin America.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL RESPIRATORY DIAGNOSTICS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL RESPIRATORY DIAGNOSTICS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE

  • 5.1 Overview
  • 5.2 Mechanical Tests
  • 5.3 OSA Diagnostic Tests
  • 5.4 Imaging Tests
  • 5.5 Molecular Diagnostic Tests
  • 5.6 Others

6 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES

  • 6.1 Overview
  • 6.2 Instruments & Devices
  • 6.3 Assays and Reagents
  • 6.4 Services and Software

7 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY END USER

  • 7.1 Overview
  • 7.2 Hospital/Clinical Laboratories
  • 7.3 Reference Laboratories
  • 7.4 Physician Offices
  • 7.5 Other End Users

8 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL RESPIRATORY DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market ranking
  • 9.3 Vendor Landscape
  • 9.4 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Philips Healthcare
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Becton, Dickinson & Company
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Abbott Laboratories
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Thermo Fisher Scientific Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Alere Inc.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Bio-Rad Laboratories, Inc.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Cosmed
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Seegene Inc.
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Sdi Diagnostic
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments

11 APPENDIX

  • 11.1 Related Research